TransMedics to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX) will announce its fourth quarter and full year 2021 financial results on February 23, 2022, after market close. A conference call to discuss the results will take place at 4:30 p.m. ET. The company specializes in portable extracorporeal warm perfusion for organ transplants, aiming to enhance organ availability for patients with end-stage conditions. Interested investors can access the call via phone or through a live webcast available on their website.

Positive

• Company is focused on improving organ transplant therapy for critical patients.
• TransMedics is recognized as a leader in organ preservation and assessment.

Negative

• None.

ANDOVER, Mass., Feb. 9, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the fourth quarter and full year 2021 after market close on Wednesday, February 23, 2022. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (833) 378-1026 for domestic callers or (236) 712-2500 for international callers, followed by Conference ID: 9789660. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-fourth-quarter-and-full-year-2021-financial-results-on-february-23-2022-301476600.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics report its fourth quarter 2021 financial results?

TransMedics will release its fourth quarter 2021 financial results on February 23, 2022.

What time is the TransMedics conference call scheduled?

The conference call is scheduled for 4:30 p.m. ET on February 23, 2022.

How can I listen to the TransMedics conference call?

You can listen to the conference call by dialing (833) 378-1026 for domestic calls or (236) 712-2500 for international calls, using the Conference ID: 9789660.

What is TransMedics' focus in the medical technology field?

TransMedics focuses on transforming organ transplant therapy for patients suffering from end-stage lung, heart, and liver failure.